Griffon Corp (GFF) financials
Griffon revenue and earnings by year
Griffon's revenue was $2.52 billion in the fiscal year to September 30, 2025, down 3.9% from the year before. Net income was $51.1 million, 2.0% of revenue. Since the fiscal year to September 30, 2016, revenue has grown 6.1% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.52 | 2.62 | 2.69 | 2.85 | 2.27 | 2.07 | 1.87 | 1.98 | 1.52 | 1.48 |
| Revenue growth | -3.9% | -2.3% | -5.7% | 25.4% | 9.9% | 10.3% | -5.2% | 29.7% | 3.2% | — |
| Gross profit | 1.06 | 1.02 | 0.95 | 0.94 | 0.64 | 0.58 | 0.52 | 0.51 | 0.41 | 0.40 |
| Gross margin | 42.0% | 38.9% | 35.3% | 32.9% | 28.2% | 28.3% | 27.6% | 25.9% | 26.8% | 27.1% |
| Operating income | 0.21 | 0.40 | 0.20 | -0.19 | 0.17 | 0.14 | 0.11 | 0.09 | 0.07 | 0.08 |
| Operating margin | 8.2% | 15.2% | 7.3% | -6.6% | 7.5% | 6.8% | 5.8% | 4.7% | 4.4% | 5.6% |
| Net income | 0.05 | 0.21 | 0.08 | -0.19 | 0.08 | 0.05 | 0.04 | 0.13 | 0.01 | 0.03 |
| Net margin | 2.0% | 8.0% | 2.9% | -6.7% | 3.5% | 2.6% | 2.0% | 6.4% | 1.0% | 2.0% |
| Diluted EPS | $1.09 | $4.23 | $1.42 | -$3.71 | $1.48 | $1.19 | $0.87 | $2.96 | $0.35 | — |
| Free cash flow | 0.32 | 0.33 | 0.39 | 0.03 | 0.08 | 0.09 | 0.08 | -0.04 | 0.06 | 0.05 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open GFF in Markets.
See also: GFF valuation and P/E history · GFF returns
No forecast, no recommendation. This page describes Griffon Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.